AZTR compared with AYTU: revenue, margins and what each company keeps, and the suppliers and customers both name

AZTRAzitra, Inc.

Mkt capRevenueRevenue

AYTUAytu Biopharma, Inc

Mkt capRevenueRevenue

Compare

AZTRAzitra, Inc.

AYTUAytu Biopharma, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AZTRAzitra, Inc.

0.82▼−7.22%· post 0.80

Mkt cap$5.4MRevenue$7,500Q2 FY24Revenue—

AYTUAytu Biopharma, Inc

1.90▼−1.55%· post 1.93

ClosedNov 4 '26

Mkt cap$21.0MRevenue$16MQ4 FY26Revenue$58MFY26

Compare

ClosedNov 4 '26

AZTRAzitra, Inc.

AYTUAytu Biopharma, Inc

0.82▼−7.22%post 0.80

Price

1.90▼−1.55%post 1.93

$5.4M

Mkt cap

$21.0M

Q2 FY24$7,500

Revenue

$16MQ4 FY26

—

Revenue

$58MFY26

AZTR0.82▼−7.22%vsAYTU1.90▼−1.55%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AZTR: latest quarter is a loss; flow not drawable. AYTU: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AZTR 1

—Fred Hutchinson Cancer Centerunlistedsupplier

Shared 0

No shared counterparties.

Only AYTU 7

—Halo Pharmaceuticalunlistedsupplier

—Mission Pharmacalunlistedsupplier

—Tris Pharmaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Fabre-Kramerunlistedsupplier

3 more · AYTU chain ›

Price

rebased to 0%

AZTR, solidAYTU, dashed